Skip to content

Comparative study of bupivacaine liposomes for ultrasound-guided rectus sheath combined with transversus abdominal plane block and local infiltration anesthesia for postoperative analgesia in laparoscopic gynecological surgery

Comparative study of bupivacaine liposomes for ultrasound-guided rectus sheath combined with transversus abdominal plane block and local infiltration anesthesia for postoperative analgesia in laparoscopic gynecological surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101021
Enrollment
Unknown
Registered
2025-04-18
Start date
2025-04-18
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Transverse fascia plane combined with posterior sheath block of rectus abdominis (block group):Patients in the block group underwent ultrasound-guided bilateral transversal plane block combined with p
Incision local infiltration group(incision group):Patients in the incision group were subjected to local infiltration by surgeons, and the injection dosage of local anesthetics was as follows: in the

Sponsors

Zhongshan Hospital(Xiamen), Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. It is planned to undergo four-port laparoscopic gynecological surgery in Xiamen Hospital, Zhongshan Hospital affiliated to Fudan University, including laparoscopic total hysterectomy, laparoscopic total hysterectomy, unilateral (double) adnexectomy and laparoscopic oophorectomy. 2. Patients aged 18-75 years. 3. The anesthesia method is compound anesthesia, that is, general anesthesia combined transverse plane abdominis combined with rectus abdominis sheath block or general anesthesia combined with local incision infiltration. 4. American Standards Association (ASA) grade I.-III. before surgery. 5. Those who voluntarily participate in this clinical study.

Exclusion criteria

Exclusion criteria: 1. Those who are unable to cooperate, communicate, and make an accurate assessment of their own pain; 2. Patients with liver and kidney insufficiency; 3. Allergy to bupivacaine liposomes or bupivacaine; 4. Have a history of chronic pain, a history of opioid abuse in the past, and a history of long-term alcohol consumption; 5. Severe hemodynamic instability, serious underlying diseases and other disorders; 6. Those who refuse to use analgesic pumps; 7. Patients with anxiety, depression and other psychological diseases before surgery.

Design outcomes

Primary

MeasureTime frame
Cumulative opioid consumption in the 72h post-operative period, calculated as morphine equivalent.;

Secondary

MeasureTime frame
NRS scores at rest and exercise 2h, 6h, 12h, 24h, 48h, 72h after surgery;Quality of sleep on the night of surgery;Quality of recovery at 24h, 48h, and 72h;The time of the patient's first outbreak of pain, and the clinician's remedy for the pain;The occurrence of adverse anesthetic reactions within 3 days after surgery;Patient's first time out of bed activity;Total length of stay;Drain extraction time;

Countries

China

Contacts

Public ContactZhiyao Wang

Zhongshan Hospital, Fudan University; Zhongshan Hospital(Xiamen), Fudan University

zhiyaowang_0313@163.com+86 150 2152 1161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026